KRYS

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Krystal Biotech Inc

NASDAQ | KRYS

188.05

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 14, 2025)

$5.35B

Market Cap

37.63

P/E Ratio

4.91

EPS

$207.84

52 Week High

$122.80

52 Week Low

HEALTHCARE

Sector

KRYS Chart

Recent Chart
Price Action

KRYS Technicals

Tags:

KRYS Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $270M
Total Revenue $291M
Cost Of Revenue $20M
Costof Goods And Services Sold $20M
Operating Income $66M
Selling General And Administrative $114M
Research And Development $54M
Operating Expenses $205M
Investment Income Net -
Net Interest Income $30M
Interest Income $30M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $6.7M
Income Before Tax $95M
Income Tax Expense $6.2M
Interest And Debt Expense -
Net Income From Continuing Operations $89M
Comprehensive Income Net Of Tax -
Ebit $103M
Ebitda $110M
Net Income $89M

Revenue & Profitability

Earnings Performance

KRYS Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $1.1B
Total Current Assets $742M
Cash And Cash Equivalents At Carrying Value $345M
Cash And Short Term Investments $345M
Inventory $27M
Current Net Receivables $105M
Total Non Current Assets $314M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $152M
Short Term Investments $253M
Other Current Assets $13M
Other Non Current Assets -
Total Liabilities $109M
Total Current Liabilities $102M
Current Accounts Payable $5M
Deferred Revenue -
Current Debt -
Short Term Debt $1.2M
Total Non Current Liabilities $7.5M
Capital Lease Obligations $7.3M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $7.3M
Other Current Liabilities $92M
Other Non Current Liabilities $1.4M
Total Shareholder Equity $946M
Treasury Stock -
Retained Earnings -$181M
Common Stock -
Common Stock Shares Outstanding $30M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $123M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $6.7M
Capital Expenditures $4.2M
Change In Receivables -
Change In Inventory -$12M
Profit Loss -
Cashflow From Investment -$163M
Cashflow From Financing $27M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $89M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $270M
Total Revenue $291M
Cost Of Revenue $20M
Costof Goods And Services Sold $20M
Operating Income $66M
Selling General And Administrative $114M
Research And Development $54M
Operating Expenses $205M
Investment Income Net -
Net Interest Income $30M
Interest Income $30M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $6.7M
Income Before Tax $95M
Income Tax Expense $6.2M
Interest And Debt Expense -
Net Income From Continuing Operations $89M
Comprehensive Income Net Of Tax -
Ebit $103M
Ebitda $110M
Net Income $89M

KRYS News

KRYS Profile

Krystal Biotech Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Krystal Biotech, Inc. is a clinical-stage biotechnology company headquartered in Pittsburgh, Pennsylvania, focused on developing redosable gene therapies to address serious rare diseases. With a robust pipeline of innovative treatments, Krystal leverages its proprietary platform to deliver sustained therapeutic benefits, aiming to improve the lives of patients with unmet medical needs. The company's commitment to advancing gene therapy positions it as a promising player in the biotech landscape, with significant potential for growth and impact in the treatment of rare genetic disorders.

VHAI
+66.66%
$0.00
YYAI
-11.76%
$0.15
BURU
-20.39%
$0.40
UGRO
+54.52%
$0.57
NVDA
-4.40%
$180.03
CGBS
-39.47%
$0.03
PLUG
+6.26%
$4.14
BITF
+28.33%
$5.39
NVTS
+26.07%
$12.57
TMQ
+59.90%
$10.49
RGTI
+2.20%
$56.12
CAN
+18.42%
$1.80
DNN
+3.73%
$3.19
INTC
-4.27%
$35.63
LAES
+24.79%
$7.65
BYND
-23.22%
$0.79
JOBY
+8.05%
$18.12
RR
+4.34%
$6.73
RXRX
+6.50%
$5.89
SSKN
+41.55%
$2.18
ITP
+31.05%
$0.34
F
+1.08%
$11.66
EDHL
+114.42%
$1.07
CRML
+28.73%
$29.97
WULF
+10.42%
$15.46
ACHR
+1.91%
$13.01
BBD
+1.94%
$3.15
SOUN
+8.98%
$20.86
NAK
+4.13%
$2.76
TLRY
-5.32%
$1.60
QBTS
+5.93%
$43.03
DVLT
+24.76%
$2.12
IONZ
+11.73%
$2.57
BTBT
+3.25%
$4.13
GPUS
-6.93%
$0.40
TSLA
-1.52%
$429.24
MARA
+9.88%
$22.24
AMD
+0.77%
$218.09
SOFI
+2.68%
$27.87
AXDX
-61.36%
$0.03
CLF
+0.83%
$13.94
QS
+15.57%
$16.98
ERIC
+20.56%
$9.85
RIG
-2.65%
$3.11
ETHD
+6.60%
$3.55
CIFR
+2.70%
$20.89
NIO
-5.15%
$6.81
QUBT
+1.49%
$21.78
NUAI
+30.63%
$3.07
UAMY
+4.54%
$17.47
ASST
-7.69%
$0.99
NOK
+4.28%
$5.47
CLSK
+9.68%
$21.98
PLTR
+1.42%
$179.74
APLD
+2.33%
$35.04
IREN
+8.16%
$69.37
AREC
+36.74%
$6.81
ABAT
+36.59%
$9.22
RF
+2.44%
$25.16
BTG
+0.56%
$5.34
KDLY
-1.56%
$0.85
AAL
+1.90%
$11.74
USAR
-2.72%
$37.62
UUUU
+16.86%
$23.77
PFE
-0.82%
$24.52
BAC
+2.45%
$50.06
SNAP
-1.61%
$7.92
BMNR
-6.84%
$52.96
RMBL
+60.50%
$3.21
MP
+3.78%
$98.66
ADAP
-2.59%
$0.18
AMZN
-1.69%
$216.34
T
+2.11%
$26.13
ADD
-25.47%
$0.05
JBLU
+7.91%
$4.91
ONDS
-3.70%
$10.41
AAPL
+0.04%
$247.77
SRM
+53.27%
$10.30
ATXS
+37.07%
$11.61
HPE
+0.76%
$24.99
IONQ
-5.50%
$77.56
AQMS
+198.89%
$29.62
BCRX
-8.59%
$6.43
EOSE
-0.41%
$16.98
NAKA
-7.78%
$0.78
KDP
+2.32%
$26.42
GRAB
-0.33%
$5.91
RGTZ
-4.94%
$8.84
GWH
-15.91%
$7.61
BULL
-0.08%
$11.73
DFLI
-2.54%
$1.53
ABEV
+1.16%
$2.16
VALE
+2.41%
$11.01
NB
+3.09%
$11.67
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
WLGS
-5.57%
$0.04
GDXD
+3.16%
$0.75
FHN
+2.47%
$23.00
WWR
+29.29%
$2.56
VHAI
+66.66%
$0.00
YYAI
-11.76%
$0.15
BURU
-20.39%
$0.40
UGRO
+54.52%
$0.57
NVDA
-4.40%
$180.03
CGBS
-39.47%
$0.03
PLUG
+6.26%
$4.14
BITF
+28.33%
$5.39
NVTS
+26.07%
$12.57
TMQ
+59.90%
$10.49
RGTI
+2.20%
$56.12
CAN
+18.42%
$1.80
DNN
+3.73%
$3.19
INTC
-4.27%
$35.63
LAES
+24.79%
$7.65
BYND
-23.22%
$0.79
JOBY
+8.05%
$18.12
RR
+4.34%
$6.73
RXRX
+6.50%
$5.89
SSKN
+41.55%
$2.18
ITP
+31.05%
$0.34
F
+1.08%
$11.66
EDHL
+114.42%
$1.07
CRML
+28.73%
$29.97
WULF
+10.42%
$15.46
ACHR
+1.91%
$13.01
BBD
+1.94%
$3.15
SOUN
+8.98%
$20.86
NAK
+4.13%
$2.76
TLRY
-5.32%
$1.60
QBTS
+5.93%
$43.03
DVLT
+24.76%
$2.12
IONZ
+11.73%
$2.57
BTBT
+3.25%
$4.13
GPUS
-6.93%
$0.40
TSLA
-1.52%
$429.24
MARA
+9.88%
$22.24
AMD
+0.77%
$218.09
SOFI
+2.68%
$27.87
AXDX
-61.36%
$0.03
CLF
+0.83%
$13.94
QS
+15.57%
$16.98
ERIC
+20.56%
$9.85
RIG
-2.65%
$3.11
ETHD
+6.60%
$3.55
CIFR
+2.70%
$20.89
NIO
-5.15%
$6.81
QUBT
+1.49%
$21.78
NUAI
+30.63%
$3.07
UAMY
+4.54%
$17.47
ASST
-7.69%
$0.99
NOK
+4.28%
$5.47
CLSK
+9.68%
$21.98
PLTR
+1.42%
$179.74
APLD
+2.33%
$35.04
IREN
+8.16%
$69.37
AREC
+36.74%
$6.81
ABAT
+36.59%
$9.22
RF
+2.44%
$25.16
BTG
+0.56%
$5.34
KDLY
-1.56%
$0.85
AAL
+1.90%
$11.74
USAR
-2.72%
$37.62
UUUU
+16.86%
$23.77
PFE
-0.82%
$24.52
BAC
+2.45%
$50.06
SNAP
-1.61%
$7.92
BMNR
-6.84%
$52.96
RMBL
+60.50%
$3.21
MP
+3.78%
$98.66
ADAP
-2.59%
$0.18
AMZN
-1.69%
$216.34
T
+2.11%
$26.13
ADD
-25.47%
$0.05
JBLU
+7.91%
$4.91
ONDS
-3.70%
$10.41
AAPL
+0.04%
$247.77
SRM
+53.27%
$10.30
ATXS
+37.07%
$11.61
HPE
+0.76%
$24.99
IONQ
-5.50%
$77.56
AQMS
+198.89%
$29.62
BCRX
-8.59%
$6.43
EOSE
-0.41%
$16.98
NAKA
-7.78%
$0.78
KDP
+2.32%
$26.42
GRAB
-0.33%
$5.91
RGTZ
-4.94%
$8.84
GWH
-15.91%
$7.61
BULL
-0.08%
$11.73
DFLI
-2.54%
$1.53
ABEV
+1.16%
$2.16
VALE
+2.41%
$11.01
NB
+3.09%
$11.67
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
WLGS
-5.57%
$0.04
GDXD
+3.16%
$0.75
FHN
+2.47%
$23.00
WWR
+29.29%
$2.56
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.